The people behind the ideas.
The ideas behind the companies.
Runway’s
Cristóbal Valenzuela
on AI-driven art and lifelong learning 
Deepgram’s
Scott Stephenson
on revolutionizing voice AI and building a developer tool 
A-Alpha Bio’s
David Younger
on advancing drug discovery and the role of company culture 
Common Room’s
Linda Lian
on integrating community into your company 
Pulumi’s
Joe Duffy
on bringing more power to developers 
RelationalAI’s
Molham Aref
on finding investors who believe in your passion Company List
Initial Investment Stage
-
Modulus Therapeutics is a seed-stage cell therapy design studio developing an internal pipeline of NK cell anti-solid tumor programs. Failures in cell therapy efficacy can be traced to poor conceptualization, design and integration of engineered components. Modulus is uniting whole-cell synthetic biology with machine learning into a cell therapy design solution to dramatically reduce pipeline risk and accelerate the path to the clinic. The team is a diverse group of cell therapy veterans along with bioengineering and machine learning experts laser focused on driving therapeutic efficacy by accessing the full cell design space.Initial Investment2021Modulus Therapeutics is a seed-stage cell therapy design studio developing an internal pipeline of NK cell anti-solid tumor programs. Failures in cell therapy efficacy can be traced to poor conceptualization, design and integration of engineered components. Modulus is uniting whole-cell synthetic biology with machine learning into a cell therapy design solution to dramatically reduce pipeline risk and accelerate the path to the clinic. The team is a diverse group of cell therapy veterans along with bioengineering and machine learning experts laser focused on driving therapeutic efficacy by accessing the full cell design space.FoundersBryce Daines
Max DarnellInvestment JourneyAcquired by Ginkgo Bioworks
2024Initial Investment2021 -
Proof is a startup working to make powerful CRISPR-based molecular testing affordable and accessible to everyoneInitial Investment2020Proof is a startup working to make powerful CRISPR-based molecular testing affordable and accessible to everyoneFoundersFeng Zhang
Jonathan Gootenberg
Omar Abudayyeh
Siddharth ShenaiInvestment JourneyAcquired by Ginkgo Bioworks
2024Initial Investment2020